Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

New EU HTA Consortium Prepares To Launch

Executive Summary

Two new groups have been formed in preparation for the application of the EU regulation on health technology assessment cooperation.

You may also be interested in...



EU Regulator & HTA Bodies Prepare The Ground For New Collaborations

The European Medicines Agency and EU national health technology assessment agencies have agreed a joint work plan to prepare for implementation of the new HTA regulations, including joint clinical assessments.

Firms Told To Get Ready Now For New EU HTA Regulation

Comparator selection and joint scientific consultation slots are among top concerns for companies operating in the EU as EUnetHTA 21 consortium preparations for new HTA regulations get going.

What’s Next? Five Things To Look Out For In December

As 2021 draws to a close, Coherus BioSciences awaits word on its FDA filing for biosimilar Humira, while Pfizer plots a submission for a designation for interchangeability, aiming to emulate that enjoyed by Boehringer Ingelheim’s Cyltezo. Aurobindo will also plan for the exit of popular managing director Narayanan Govindarajan.

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

PS145198

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel